J17 Capital has its sights focused squarely on North America with the aim of investing in and bringing needed capital to technology, pharmaceutical, and therapeutic industries. Our hope is to bring funding and investment to those who need it most to help hasten the development of business, speed up the R&D of new beneficial technology and increase the delivery of new advancements in life-improving medicine.